<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR23">
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Bayon</surname>
    <given-names>E</given-names>
   </name>
   <name>
    <surname>Morlieras</surname>
    <given-names>J</given-names>
   </name>
   <name>
    <surname>Dereuddre-Bosquet</surname>
    <given-names>N</given-names>
   </name>
   <name>
    <surname>Gonon</surname>
    <given-names>A</given-names>
   </name>
   <name>
    <surname>Gosse</surname>
    <given-names>L</given-names>
   </name>
   <name>
    <surname>Courant</surname>
    <given-names>T</given-names>
   </name>
   <name>
    <surname>Le Grand</surname>
    <given-names>R</given-names>
   </name>
   <name>
    <surname>Marche</surname>
    <given-names>PN</given-names>
   </name>
   <name>
    <surname>Navarro</surname>
    <given-names>FP</given-names>
   </name>
  </person-group>
  <article-title>Overcoming immunogenicity issues of HIV p 24 antigen by the use of innovative nanostructured lipid carriers as delivery systems: evidences in mice and non-human primates</article-title>
  <source>NPJ Vaccines</source>
  <year>2018</year>
  <volume>3</volume>
  <fpage>46</fpage>
  <pub-id pub-id-type="doi">10.1038/s41541-018-0086-0</pub-id>
  <?supplied-pmid 30302284?>
  <pub-id pub-id-type="pmid">30302284</pub-id>
 </element-citation>
</ref>
